OLFML2A is necessary for anti-triple negative breast cancer effect of selective activator protein‐1 inhibitor T-5224-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OLFML2A is necessary for anti-triple negative breast cancer effect of selective activator protein‐1 inhibitor T-5224

Published:2021-08 Issue:8 Volume:14 Page:101100
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Zhao Qian,Zhang Kaixin,Li Yong,Ren Yaxuan,Shi Jikang,Gu Yulu,Qiu Shuang,Liu Sainan,Cheng Yi,Qiao Yichun,Liu Yawen^ORCID

Funder

Jilin Provincial Science and Technology Department

Health and Family Planning Commission of Jilin Province

Jilin Province People's Government Department of Education

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J];Sung;CA Cancer J Clin.,2021

2. Triple-Negative Breast Cancer [J];Foulkes;N. Engl. J. Med.,2010

3. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up [J];Malorni;Breast Cancer Res. Treat.,2012

4. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer [J];Liedtke;J. Clin. Oncol.,2008

5. Pattern of metastatic spread in triple-negative breast cancer [J];Dent;Breast Cancer Res. Treat.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A CD8+ T cell related immune score predicts survival and refines the risk assessment in acute myeloid leukemia;Frontiers in Immunology;2024-09-12

2. HTB50-2 Inhibits Growth and Migration of Triple-negative Breast Cancer via FOSL2/FOXC1 Signaling Axis and Subsequent Ferroptosis;Current Medicinal Chemistry;2024-08-09

3. Identification of m6A methylation-related genes in cerebral ischaemia‒reperfusion of Breviscapus therapy based on bioinformatics methods;BMC Medical Genomics;2023-09-05

4. Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs;Translational Cancer Research;2023-09

5. Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis;Frontiers in Cell and Developmental Biology;2023-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3